ChemoCentryx
CCXI
#3708
Rank
HK$29.33 B
Marketcap
HK$407.93
Share price
0.00%
Change (1 day)
34.85%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): -HK$14.78

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -HK$14.83. In 2021 the company made an earnings per share (EPS) of -HK$14.83 a decrease over its 2020 EPS that were of -HK$6.36.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-HK$14.78-0.37%
2021-HK$14.83133.33%
2020-HK$6.36-16.49%
2019-HK$7.6127.63%
2018-HK$5.96-305.41%
2017HK$2.90-142.53%
2016-HK$6.83-19.44%
2015-HK$8.47-0%
2014-HK$8.4713.68%
2013-HK$7.45-16.67%
2012-HK$8.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.53-562.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$5.96-140.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$28.01-288.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$127.27-958.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$44.57-400.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$9.93-166.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.62-340.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$25.09-269.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$4.94-133.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel